Effects of cigarette smoking on neuropsychological performance in mood disorders: A comparison between smoking and nonsmoking inpatients

Journal of Clinical Psychiatry

Volumn 74, Issue 2, 2013, Pages

  Caldirola, Daniela ^a   Daccò, Silvia ^a   Grassi, Massimiliano ^a   Citterio, Alessandra ^a   Menotti, Roberta ^a   Cavedini, Paolo ^a   Girardi, Paolo ^d   Perna, Giampaolo ^a,b,c  

^a San Benedetto Hospital   (Italy)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGOMELATINE; AMFEBUTAMONE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; MIRTAZAPINE; MOOD STABILIZER; NEUROLEPTIC AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; ATTENTION; BIPOLAR DISORDER; COGNITION; COMPREHENSION; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; FEMALE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INTERVIEW; LANGUAGE ABILITY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL CAPACITY; MENTAL PERFORMANCE; MOOD DISORDER; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOMETRY; REHABILITATION CARE; SMOKING; TREATMENT DURATION; VERBAL MEMORY; VISUAL MEMORY; WORKING MEMORY;

EID: 84874620130     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.12m07985     Document Type: Article

References (66)

1. Dome P, Lazary J, Kalapos MP, et al. Smoking, nicotine and neuropsychiatric disorders. Neurosci Biobehav Rev. 2010;34(3):295-342. doi:10.1016/j.neubiorev.209.07.013 PubMed
2. Wing VC, Wass CE, Soh DW, et al. A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia. Ann N Y Acad Sci. 2012;1248(1):89-106. doi:10.1/j.1749-632. 201.06261.x PubMed
3. Cosci F, Knuts IJ, Abrams K, et al. Cigarette smoking and panic: a critical review of the literature. J Clin Psychiatry. 2010;71(5):606-615. doi:10.408/JCP.08r04523blu PubMed
4. Diaz FJ, James D, Botts S, et al. Tobacco smoking behaviors in bipolar disorder: a comparison of the general population, schizophrenia, and major depression. Bipolar Disord. 2009;11(2):154-165. doi:10.1/j.139-5618.209.064.x PubMed
5. Boden JM, Fergusson DM, Horwood LJ. Cigarette smoking and depression: tests of causal linkages using a longitudinal birth cohort. Br J Psychiatry. 2010;196(6):440-446. doi:10.192/bjp.bp.109.065912 PubMed
6. Heffner JL, Strawn JR, DelBello MP, et al. The co-occurrence of cigarette smoking and bipolar disorder: phenomenology and treatment considerations. Bipolar Disord. 2011;13(5-6):439-453. doi:10.1/j.139-5618.201.0943.x PubMed
7. Ostacher MJ, Nierenberg AA, Perlis RH, et al. The relationship between smoking and suicidal behavior, comorbidity, and course of illness in bipolar disorder. J Clin Psychiatry. 2006;67(12):1907-1911. doi:10.408/JCP.v67n1210 PubMed (Pubitemid 46048187)
8. Breslau N, Peterson EL, Schultz LR, et al. Major depression and stages of smoking: a longitudinal investigation. Arch Gen Psychiatry. 1998;55(2): 161-166. doi:10.101/archpsyc.5.2.161 PubMed (Pubitemid 28087602)
9. Fergusson DM, Goodwin RD, Horwood LJ. Major depression and cigarette smoking: results of a 21-year longitudinal study. Psychol Med. 2003;33(8):1357-1367. doi:10.1017/S0329170308596 PubMed (Pubitemid 37483458)
10. Mykletun A, Overland S, AarøLE, et al. Smoking in relation to anxiety and depression: evidence from a large population survey: the HUNT study. Eur Psychiatry. 2008;23(2):77-84. doi:10.1016/j.eurpsy.207.10.05 PubMed
11. Klungsør O, Nygård JF, Sørensen T, et al. Cigarette smoking and incidence of first depressive episode: an 11-year, population-based follow-up study. Am J Epidemiol. 2006;163(5):421-432. doi:10.1093/aje/kwj058 PubMed
12. Pasco JA, Williams LJ, Jacka FN, et al. Tobacco smoking as a risk factor for major depressive disorder: population-based study. Br J Psychiatry. 2008; 193(4):322-326. doi:10.192/bjp.bp.107.046706 PubMed
13. Haustein KO, Haffner S, Woodcock BG. A review of the pharmacological and psychopharmacological aspects of smoking and smoking cessation in psychiatric patients. Int J Clin Pharmacol Ther. 2002;40(9):404-418. PubMed (Pubitemid 34982369)
14. Andreasen JT, Redrobe JP. Antidepressant-like effects of nicotine and mecamylamine in the mouse forced swim and tail suspension tests: role of strain, test and sex. Behav Pharmacol. 2009;20(3):286-295. doi:10.1097/FBP. 0b013e32832c713e PubMed
15. Lewis A, Miller JH, Lea RA. Monoamine oxidase and tobacco dependence. Neurotoxicology. 2007;28(1):182-195. doi:10.1016/j.neuro.206.05.019 PubMed (Pubitemid 46187252)
16. Murphy JM, Horton NJ, Monson RR, et al. Cigarette smoking in relation to depression: historical trends from the Stirling County Study. Am J Psychiatry. 2003;160(9):1663-1669. doi:10.176/api.ajp.160.9.163 PubMed (Pubitemid 41079554)
17. Zabala A, Eguiluz JI, Segarra R, et al. Cognitive performance and cigarette smoking in first-episode psychosis. Eur Arch Psychiatry Clin Neurosci. 2009;259(2):65-71. doi:10.107/s0406-08-0835-6 PubMed
18. D'Souza MS, Markou A. Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits. Neuropharmacology. 2012;62(3):1564-1573. doi:10.1016/j.neuropharm.201.01.04 PubMed
19. Gehricke JG, Loughlin SE, Whalen CK, et al. Smoking to self-medicate attentional and emotional dysfunctions. Nicotine Tob Res. 2007;9(suppl 4): S523-S536. doi:10.1080/14620701685039 PubMed
20. Lerman C, Audrain J, Tercyak K, et al. Attention-deficit hyperactivity disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program. Nicotine Tob Res. 2001;3(4):353-359. doi:10.1080/146201072156 PubMed (Pubitemid 33101062)
21. Potter AS, Newhouse PA. Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder. Pharmacol Biochem Behav. 2008;88(4):407-417. doi:10.1016/j.pb.207.09.014 PubMed (Pubitemid 350266783)
22. Douglas KM, Porter RJ. Longitudinal assessment of neuropsychological function in major depression. Aust N Z J Psychiatry. 2009;43(12):1105-1117. doi:10.3109/04867090327987 PubMed
23. Gruber O, Zilles D, Kennel J, et al. A systematic experimental neuropsychological investigation of the functional integrity of working memory circuits in major depression. Eur Arch Psychiatry Clin Neurosci. 2011;261(3):179-184. doi:10.107/s0406-010-0165-3 PubMed
24. Hammar A, Ardal G. Cognitive functioning in major depression - a summary. Front Hum Neurosci. 2009;3:26. doi:10.389/neuro.09.026.209 PubMed
25. Law CW, Soczynska JK, Woldeyohannes HO, et al. Relation between cigarette smoking and cognitive function in euthymic individuals with bipolar disorder. Pharmacol Biochem Behav. 2009;92(1):12-16. doi:10.1016/j.pb.208.10.02 PubMed
26. Torres IJ, DeFreitas VG, DeFreitas CM, et al. Neurocognitive functioning in patients with bipolar I disorder recently recovered from a first manic episode. J Clin Psychiatry. 2010;71(9):1234-1242. doi:10.408/JCP.08m0497yel PubMed
27. Association Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
28. Heatherton TF, Kozlowski LT, Frecker RC, et al. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86(9):1119-1127. doi:10.1/j.1360-043.191. tb01879.x PubMed
29. Breslau N, Klein DF. Smoking and panic attacks: an epidemiologic investigation. Arch Gen Psychiatry. 1999;56(12):1141-1147. doi:10.101/archpsyc. 56.12.141 PubMed
30. Isensee B, Wittchen HU, Stein MB, et al. Smoking increases the risk of panic: findings from a prospective community study. Arch Gen Psychiatry. 2003;60(7):692-700. doi:10.101/archpsyc.60.7.692 PubMed (Pubitemid 36818631)
31. Novelli G, Papagno C, Capitani E, et al. Tre test clinici di memoria verbale a lungo termine. Arch Psicol Neurol Psichiatr. 1986;47:278-296.
32. Spinnler H, Tognoni G. Standardizzazione e taratura italiana di test neuropsicologici. Ital J Neurol Sci. 1987;(suppl 8):47-50.
33. Caffarra P, Vezzadini G, Dieci F, et al. Rey-Osterrieth complex figure: normative values in an Italian population sample. Neurol Sci. 2002;22(6):443-447. doi:10.107/s10720203 PubMed (Pubitemid 34436807)
34. Spinnler H, Tognoni G. Standardizzazione e taratura italiana di test neuropsicologici. Ital J Neurol Sci. 1987;(suppl 8):74-78.
35. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62. doi:10.136/jnp.23.1.56 PubMed
36. Overall JE, Beller SA. The Brief Psychiatric Rating Scale (BPRS) in geropsychiatric research, 1: factor structure on an inpatient unit. J Gerontol. 1984;39(2):187-193. PubMed (Pubitemid 14156164)
37. Araujo NB, Barca ML, Engedal K, et al. Verbal fluency in Alzheimer's disease, Parkinson's disease, and major depression. Clinics (Sao Paulo). 2011; 66(4):623-627. doi:10.1590/S1807-59320104017 PubMed
38. Godard J, Grondin S, Baruch P, et al. Psychosocial and neurocognitive profiles in depressed patients with major depressive disorder and bipolar disorder. Psychiatry Res. 2011;190(2-3):244-252. doi:10.1016/j.psychres.201.06. 014 PubMed
39. Chaiton M, Cohen J, O'Loughlin J, et al. Use of cigarettes to improve affect and depressive symptoms in a longitudinal study of adolescents. Addict Behav. 2010;35(12):1054-1060. doi:10.1016/j.adbeh.2010.07.02 PubMed
40. Lerman C, Audrain J, Orleans CT, et al. Investigation of mechanisms linking depressed mood to nicotine dependence. Addict Behav. 1996;21(1):9-19. doi:10.1016/0306-4603(95)032-1 PubMed (Pubitemid 26080739)
41. Patten CA, Gillin JC, Golshan S, et al. Relationship of mood disturbance to cigarette smoking status among 252 patients with a current mood disorder. J Clin Psychiatry. 2001;62(5):319-324. doi:10.408/JCP.v62n0502 PubMed (Pubitemid 32545551)
42. Shiffman S, Ferguson SG, Gwaltney CJ. Immediate hedonic response to smoking lapses: relationship to smoking relapse, and effects of nicotine replacement therapy. Psychopharmacology (Berl). 2006;184(3-4):608-618. doi:10.107/s0213-05-0175-4 PubMed (Pubitemid 43255877)
43. Spring B, Cook JW, Appelhans B, et al. Nicotine effects on affective response in depression-prone smokers. Psychopharmacology (Berl). 2008;196(3): 461-471. doi:10.107/s0213-07-097-7 PubMed (Pubitemid 351191177)
44. Tranel D, McNutt A, Bechara A. Smoking cessation after brain damage does not lead to increased depression: implications for understanding the psychiatric complications of varenicline. Cogn Behav Neurol. 2012;25(1): 16-24. doi:10.1097/WN.0b013e3182492a9c PubMed
45. Dagytė G, Den Boer JA, Trentani A. The cholinergic system and depression. Behav Brain Res. 2011;221(2):574-582. doi:10.1016/j.br.2010.02.023 PubMed
46. Mineur YS, Picciotto MR. Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis. Trends Pharmacol Sci. 2010;31(12): 580-586. doi:10.1016/j.tips.2010.09.04 PubMed
47. Hasselmo ME, Sarter M. Modes and models of forebrain cholinergic neuromodulation of cognition. Neuropsychopharmacology. 2011;36(1):52-73. doi:10.1038/np.2010.104 PubMed
48. Barr RS, Culhane MA, Jubelt LE, et al. The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. Neuropsychopharmacology. 2008;33(3):480-490. doi:10.1038/sj.np.1301423 PubMed
49. Dawkins L, Turner J, Hasna S, et al. The electronic-cigarette: effects on desire to smoke, withdrawal symptoms and cognition. Addict Behav. 2012;37(8): 970-973. doi:10.1016/j.adbeh.2012.03.04 PubMed
50. Dunbar G, Boeijinga PH, Demazières A, et al. Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers. Psychopharmacology (Berl). 2007;191(4):919-929. doi:10.107/s0213-06-0675-x PubMed (Pubitemid 46399143)
51. Howe WM, Ji J, Parikh V, et al. Enhancement of attentional performance by selective stimulation of alpha4beta2(.*) nAChRs: underlying cholinergic mechanisms. Neuropsychopharmacology. 2010;35(6):1391-1401. doi:10.1038/np.2010.9 PubMed
52. Kroker KS, Rast G, Rosenbrock H. Differential effects of subtype-specific nicotinic acetylcholine receptor agonists on early and late hippocampal LTP. Eur J Pharmacol. 2011;671(1-3):26-32. doi:10.1016/j.ejphar.201.09.167 PubMed
53. Olincy A, Harris JG, Johnson LL, et al. Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Arch Gen Psychiatry. 2006;63(6):630-638. doi:10.101/archpsyc.63.6.630 PubMed (Pubitemid 43848294)
54. Campbell S, MacQueen G. An update on regional brain volume differences associated with mood disorders. Curr Opin Psychiatry. 2006;19(1):25-33. doi:10.1097/01.yco.0194371.47685.f2 PubMed (Pubitemid 44406141)
55. Emsell L, McDonald C. The structural neuroimaging of bipolar disorder. Int Rev Psychiatry. 2009;21(4):297-313. doi:10.1080/09540260902962081 PubMed
56. Kempton MJ, Salvador Z, MunaføMR, et al. Structural neuroimaging studies in major depressive disorder: meta-analysis and comparison with bipolar disorder. Arch Gen Psychiatry. 2011;68(7):675-690. doi:10.101/archgenpsychiatry. 201.60 PubMed
57. Malhi GS, Ivanovski B, Hadzi-Pavlovic D, et al. Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia. Bipolar Disord. 2007;9(1-2):114-125. doi:10.1/j.139-5618.207.0324.x PubMed (Pubitemid 46671679)
58. Martínez-Arán A, Vieta E, Reinares M, et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry. 2004;161(2):262-270. doi:10.176/api.ajp.161.2.262 PubMed (Pubitemid 38419277)
59. De Luca V, Likhodi O, Van Tol HH, et al. Regulation of alpha7-nicotinic receptor subunit and alpha7-like gene expression in the prefrontal cortex of patients with bipolar disorder and schizophrenia. Acta Psychiatr Scand. 2006;114(3):211-215. doi:10.1/j.160-047.206.0785.x PubMed (Pubitemid 44186251)
60. Thomsen MS, Weyn A, Mikkelsen JD. Hippocampal α7 nicotinic acetylcholine receptor levels in patients with schizophrenia, bipolar disorder, or major depressive disorder. Bipolar Disord. 2011;13(7-8):701-707. doi:10.1/j.139-5618.201.0961.x PubMed
61. Semenova S, Contet C, Roberts AJ, et al. Mice lacking the β4 subunit of the nicotinic acetylcholine receptor show memory deficits, altered anxiety- and depression-like behavior, and diminished nicotine-induced analgesia [published online ahead of print May 9, 2012). Nicotine Tob Res. 2012. doi:10.1093/ntr/nts107 PubMed
62. Fallon S, Shearman E, Sershen H, et al. The effects of glutamate and GABA receptor antagonists on nicotine-induced neurotransmitter changes in cognitive areas. Neurochem Res. 2007;32(4-5):535-553. doi:10.107/s1064-06-913-z PubMed (Pubitemid 46481286)
63. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci. 1997;20(2):92-98. doi:10.1016/S016-236(96)1073-4 PubMed (Pubitemid 27050704)
64. Herrera-Guzmán I, Gudayol-Ferré E, Herrera-Abarca JE, et al. Major depressive disorder in recovery and neuropsychological functioning: effects of selective serotonin reuptake inhibitor and dual inhibitor depression treatments on residual cognitive deficits in patients with major depressive disorder in recovery. J Affect Disord. 2010;123(1-3):341-350. doi:10.1016/j.jad.209.10.09 PubMed
65. Videira Dias V, Balanza-Martinez V, Soeiro-de-Souza MG, et al. Pharmacological approaches in bipolar disorders and the impact on cognition: a critical overview [published online ahead of print August 20, 2012]. Acta Psychiatr Scand. 2012 PubMed
66. Stewart SA. The effects of benzodiazepines on cognition. J Clin Psychiatry. 2005;66(suppl 2):9-13. PubMed (Pubitemid 40343675)